AIL
MRNA icon

AGF Investments LLC’s Moderna MRNA Stock Holding History

AGF Investments LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,816
Closed -$715K – 489
2021
Q4 		$715K Buy
+2,816
New +$823K 0.06% 219
2021
Q3 		– Sell
-3,621
Closed -$851K – 452
2021
Q2 		$851K Sell
3,621
-511
-12% -$91.3K 0.09% 45
2021
Q1 		$541K Sell
4,132
-3,783
-48% -$548K 0.06% 221
2020
Q4 		$827K Sell
7,915
-11,779
-60% -$1.19M 0.1% 115
2020
Q3 		$1.39M Sell
19,694
-1,647
-8% -$115K 0.16% 98
2020
Q2 		$1.37M Buy
+21,341
New +$1.17M 0.14% 113

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AGF Investments LLC's MRNA Position: Q1 2022 in Review

AGF Investments LLC sold out of Moderna (MRNA) in Q1 2022, closing a stake of 2,816 shares — an estimated $715K sold.

AGF Investments LLC first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $1.39M in Q3 2020. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • AGF Investments LLC reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 2,816 Moderna shares in Q1 2022, an estimated $715K.
  • AGF Investments LLC first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • AGF Investments LLC's Moderna position peaked at $1.39M in Q3 2020.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.